home / stock / phge / phge news

PHGE News and Press, Chardan Healthcare Acquisition Corp. From 11/04/25

Stock Information
Company Name: Chardan Healthcare Acquisition Corp.
Stock Symbol: PHGE
Market: NYSE
Website: biomx.com
Menu
PHGE PHGE Quote PHGE Short PHGE News PHGE Articles PHGE Message Board
Get PHGE Alerts

News, Short Squeeze, Breakout and More Instantly...
PHGE - BiomX Announces Positive FDA Feedback Supporting Next-Generation Phage Cocktail Program for Diabetic Foot Infections

NESS ZIONA, Israel, Nov. 04, 2025 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company advancing novel natural and engineered phage therapies targeting specific pathogenic bacteria, today announced that it has receiv...
PHGE - BiomX Announces FDA Feedback Supporting Expanded Development Pathways for BX004 in Cystic Fibrosis

2025-10-17 11:00:53 ET BiomX Inc. (NYSE: PHGE ), a clinical-stage company developing natural and engineered bacteriophage therapies, announced progress in addressing regulatory feedback on its BX004 program for cystic fibrosis (CF), while also receiving new written guidance from the...

PHGE - BiomX Provides a Program Update and Announces New FDA Feedback Potentially Expanding BX004 Development Pathways

BiomX believes that it has fully addressed the FDA’s queries related to the third-party nebulizer used to deliver BX004, which are narrow in scope; an additional FDA request for limited technical clarifications on the nebulizer has also been addressed In parallel, new written FDA f...

PHGE - BiomX CEO to Present at H.C. Wainwright 27th Annual Global Investment Conference

NESS ZIONA, Israel, Sept. 04, 2025 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE), a clinical-stage company advancing natural and engineered phage therapies targeting specific pathogenic bacteria, today announced that Jonathan Solomon, the Company’s Chief Executive Officer, will pres...
PHGE - BiomX outlines BX004 Phase IIb results expected in Q1 2026 as BX211 advances toward registrational study

2025-08-13 11:49:42 ET More on BiomX BiomX Inc. (PHGE) Q2 2025 Earnings Call Transcript BiomX Inc. (PHGE) Q1 2025 Earnings Conference Call Transcript Seeking Alpha’s Quant Rating on BiomX Historical earnings data for BiomX Financial information...

PHGE - BiomX Inc. (PHGE) Q2 2025 Earnings Call Transcript

2025-08-13 11:48:40 ET BiomX Inc. (PHGE) Q2 2025 Earnings Conference Call August 13, 2025, 8:00 AM ET Company Participants Jonathan Eitan Solomon - CEO & Director Marina Wolfson - CFO & Secretary Conference Call Participants I-Eh Jen - Laidlaw &am...

PHGE - BiomX GAAP EPS of -$0.19

2025-08-13 07:28:13 ET More on BiomX BiomX Inc. (PHGE) Q1 2025 Earnings Conference Call Transcript Seeking Alpha’s Quant Rating on BiomX Historical earnings data for BiomX Financial information for BiomX Read the full article on Seeking Alpha...
PHGE - BiomX Reports Second Quarter 2025 Financial Results and Provides Program Updates

Positive Phase 2 results for BX211 demonstrated >40% wound size reduction vs. placebo in diabetic foot osteomyelitis patients; Planning underway for potential registrational study Nature Communications publication of new BX004 Phase 1b/2a data demonstrated further ~500-fold (2.7 log&#x...

PHGE - US Companies Moving the Markets, Evening edition
Wed, Aug 06, 2025 as of 4:00 pm ET

A look at the top 10 most actives in the United States Safe & Green Holdings Corp. (SGBX) rose 89.9% to $0.367 on volume of 1,005,648,857 shares Opendoor Technologies Inc (OPEN) fell 24.6% to $1.9 on volume of 206,486,229 shares BiomX Inc. (PHGE) rose 49.4% to $0.65 on volume of 196,235...

PHGE - US Companies Moving the Markets, Morning edition
Wed, Aug 06, 2025 as of 10.00 am ET

A look at the top 10 most actives in the United States Safe & Green Holdings Corp. (SGBX) rose 141.6% to $0.4671 on volume of 363,657,432 shares BiomX Inc. (PHGE) rose 19.6% to $0.5201 on volume of 78,449,319 shares LivePerson Inc. (LPSN) rose 39.7% to $1.2404 on volume of 64,019,403 sh...
Previous 10 Next 10